TradingView review

TradingView is the pick if your screen has to reach beyond US exchanges. Its pricing page lists stock, ETF and crypto screeners covering 150+ exchanges from 50+ countries with 500+ fundamental and technical fields, and results can switch to a chart view or a heatmap. The Pine Screener lets you scan assets with your own scripts or community scripts, and separate bond and crypto screeners filter by yield, maturity, credit rating or market cap. The free Basic plan includes the core screeners, but it is tight elsewhere: 1 watchlist of 30 symbols and 3 active price alerts. Paid tiers named Essential, Plus, Premium and Ultimate raise those limits, with up to 1,000 price alerts and AI screener requests from 100 to 500. We could not confirm USD prices because the page showed PLN from our location, so check the price in your own currency before you subscribe.

Who it is for

chart-led traders who screen markets outside the US

Price

Free Basic plan; see vendor pricing (USD check pending).

US price check pending. See the vendor pricing page.

Key features

• Stock, ETF and crypto screeners on every plan
• Screens 150+ exchanges from 50+ countries with 500+ fundamental and technical fields
• Chart view and heatmap view for screener results
• Pine Screener scans assets with your own or community scripts
• Bond screener with filters for yield, maturity and credit rating

Strengths and weaknesses

• Strength: Free Basic plan includes the stock, ETF and crypto screeners
• Strength: Watchlists can be used as screener filters
• Strength: Paid tiers raise active price alerts from 3 on Basic up to 1,000
• Weakness: Pricing page showed prices in PLN from our location, so USD prices are pending
• Weakness: Basic allows 1 watchlist with 30 symbols
• Weakness: Pine Screener and data export sit on paid plans

Key facts

• Coverage: 150+ exchanges, 50+ countries
• Screener fields: 500+ fundamental and technical
• Free plan: Yes, Basic
• Price alerts: 3 on Basic, up to 1,000 on paid plans

Where it ranks

TradingView is No. 2 in our Best Stock Screeners verdict.